Professor Philip Barter
University of New South Wales Sydney, Sydney (Australia)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
PCSK9 inhibition: science, outcomes and guidance (EBAC Accredited)
Event: ESC Congress 2018
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
State-of-the-art lipid treatment in coronary patients in 2017
Event: ESC Congress 2017
Topic: Lipids (Epidemiology and Prevention)
Session type: Satellite Symposium
ESC 365 is supported by
